Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.1B | 3.0B | 3.4B | 3.7B |
Cost of revenue | 1.5B | 2.0B | 2.4B | 2.6B |
Gross profit | 661.4M | 962.0M | 970.9M | 1.1B |
Operating expense | ||||
Research & development | 53.1M | 91.0M | 67.8M | 69.9M |
Selling general and admin | 586.1M | -1.0B | 1.5B | -192.9M |
Other operating expenses | 16.1M | 43.1M | 27.3M | 23.1M |
Operating income | 157.5M | 80.8M | 280.2M | 378.0M |
Non operating interest income | ||||
Income | 13.0M | 13.0M | 6.8M | 7.6M |
Expense | 42.4M | 48.3M | 48.6M | 50.9M |
Other income expense | — | — | — | — |
Pretax income | 120.8M | -149.8M | 234.4M | 140.1M |
Tax provision | 15.1M | -57.0M | 36.2M | -20.6M |
Net income | 105.7M | -92.7M | 198.1M | 160.7M |
Basic EPS | 0.2 | — | — | — |
Diluted EPS | 0.2 | — | — | — |
Basic average shares | 525.8M | — | — | — |
Diluted average shares | 525.8M | — | — | — |
EBITDA | 168.1M | 87.9M | 286.1M | 378.7M |
Net income from continuing op. | — | — | — | — |
Minority interests | -587.0K | 14.3M | 2.2M | 2.3M |
Preferred stock dividends | 0 | 0 | 0 | 0 |